247 related articles for article (PubMed ID: 33116411)
1. Dexmedetomidine Attenuates Cellular Injury and Apoptosis in H9c2 Cardiomyocytes by Regulating p-38MAPK and Endoplasmic Reticulum Stress.
Zhu Z; Ling X; Zhou H; Zhang C; Yan W
Drug Des Devel Ther; 2020; 14():4231-4243. PubMed ID: 33116411
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway.
Chu Y; Teng J; Feng P; Liu H; Wang F; Wang H
Pharmacology; 2022; 107(1-2):14-27. PubMed ID: 34718238
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway.
Zhang Y; Zhao Q; Li X; Ji F
Mol Cell Biochem; 2021 Jul; 476(7):2803-2812. PubMed ID: 33725228
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine at a dose of 1 µM attenuates H9c2 cardiomyocyte injury under 3 h of hypoxia exposure and 3 h of reoxygenation through the inhibition of endoplasmic reticulum stress.
Zhu Z; Ling X; Zhou H; Zhang C
Exp Ther Med; 2021 Feb; 21(2):132. PubMed ID: 33376514
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of dexmedetomidine on hypoxia/reoxygenation injury in cardiomyocytes by regulating the CHOP signaling pathway.
Shi X; Liu Z; Li J
Mol Med Rep; 2020 Oct; 22(4):3307-3315. PubMed ID: 32945482
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress.
Li J; Zhao Y; Zhou N; Li L; Li K
J Diabetes Res; 2019; 2019():7869318. PubMed ID: 31886285
[TBL] [Abstract][Full Text] [Related]
7. The protective effect of lycopene on hypoxia/reoxygenation-induced endoplasmic reticulum stress in H9C2 cardiomyocytes.
Gao Y; Jia P; Shu W; Jia D
Eur J Pharmacol; 2016 Mar; 774():71-9. PubMed ID: 26845695
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine attenuates neuronal injury after spinal cord ischaemia-reperfusion injury by targeting the CNPY2-endoplasmic reticulum stress signalling.
Zhao L; Zhai M; Yang X; Guo H; Cao Y; Wang D; Li P; Liu C
J Cell Mol Med; 2019 Dec; 23(12):8173-8183. PubMed ID: 31625681
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling.
Yuan M; Meng XW; Ma J; Liu H; Song SY; Chen QC; Liu HY; Zhang J; Song N; Ji FH; Peng K
Drug Des Devel Ther; 2019; 13():3137-3149. PubMed ID: 31564830
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine attenuates hepatic ischemia-reperfusion injury-induced apoptosis via reducing oxidative stress and endoplasmic reticulum stress.
Zhang S; Tang J; Sun C; Zhang N; Ning X; Li X; Wang J
Int Immunopharmacol; 2023 Apr; 117():109959. PubMed ID: 36881980
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic preconditioning protects microvascular endothelial cells against hypoxia/reoxygenation injury by attenuating endoplasmic reticulum stress.
Wu XD; Zhang ZY; Sun S; Li YZ; Wang XR; Zhu XQ; Li WH; Liu XH
Apoptosis; 2013 Jan; 18(1):85-98. PubMed ID: 23108759
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 attenuates endoplasmic reticulum stress-induced apoptosis in H9c2 cardiomyocytes during hypoxia/reoxygenation through the GLP-1R/PI3K/Akt pathways.
Guan G; Zhang J; Liu S; Huang W; Gong Y; Gu X
Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):715-722. PubMed ID: 30762075
[TBL] [Abstract][Full Text] [Related]
13. cFLIP
Li YZ; Wu H; Liu D; Yang J; Yang J; Ding JW; Zhou G; Zhang J; Zhang D
Cardiovasc Drugs Ther; 2023 Apr; 37(2):225-238. PubMed ID: 34767133
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury via multiple mechanisms.
Cai S; Liu Y; Cheng Y; Yuan J; Fang J
J Clin Lab Anal; 2022 Jul; 36(7):e24119. PubMed ID: 34882841
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling.
Yang FY; Zhang L; Zheng Y; Dong H
Bioengineered; 2022 Jan; 13(1):1377-1387. PubMed ID: 34974801
[TBL] [Abstract][Full Text] [Related]
16. B-type natriuretic peptide attenuates endoplasmic reticulum stress in H9c2 cardiomyocytes underwent hypoxia/reoxygenation injury under high glucose/high fat conditions.
Chang P; Zhang M; Zhang X; Li G; Hu H; Wu J; Wang X; Yang Z; Zhang J; Chen W; Ren M; Li X; Zhu M; Chen B; Yu J
Peptides; 2019 Jan; 111():103-111. PubMed ID: 29689346
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting (pro)renin receptor-mediated p38 MAPK signaling decreases hypoxia/reoxygenation-induced apoptosis in H9c2 cells.
Liu Y; Zhang S; Su D; Liu J; Cheng Y; Zou L; Li W; Jiang Y
Mol Cell Biochem; 2015 May; 403(1-2):267-76. PubMed ID: 25711402
[TBL] [Abstract][Full Text] [Related]
18. Curcumin attenuates hypoxia/reoxygenation‑induced myocardial injury.
Wei W; Peng J; Li J
Mol Med Rep; 2019 Dec; 20(6):4821-4830. PubMed ID: 31638219
[TBL] [Abstract][Full Text] [Related]
19. Ferroptosis Is Involved in Diabetes Myocardial Ischemia/Reperfusion Injury Through Endoplasmic Reticulum Stress.
Li W; Li W; Leng Y; Xiong Y; Xia Z
DNA Cell Biol; 2020 Feb; 39(2):210-225. PubMed ID: 31809190
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine protects against oxygen-glucose deprivation/reoxygenation injury-induced apoptosis via the p38 MAPK/ERK signalling pathway.
Wang K; Zhu Y
J Int Med Res; 2018 Feb; 46(2):675-686. PubMed ID: 29210287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
